Imbalance of growth factor signalling in diabetic kidney disease: is connective tissue growth factor (CTGF, CCN2) the perfect intervention point? - PubMed (original) (raw)
Comparative Study
doi: 10.1093/ndt/gfh570. Epub 2004 Nov 16.
- PMID: 15546890
- DOI: 10.1093/ndt/gfh570
Comparative Study
Imbalance of growth factor signalling in diabetic kidney disease: is connective tissue growth factor (CTGF, CCN2) the perfect intervention point?
Frans A van Nieuwenhoven et al. Nephrol Dial Transplant. 2005 Jan.
No abstract available
Similar articles
- Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: possible predictive marker for incipient diabetic nephropathy.
Thomson SE, McLennan SV, Kirwan PD, Heffernan SJ, Hennessy A, Yue DK, Twigg SM. Thomson SE, et al. J Diabetes Complications. 2008 Jul-Aug;22(4):284-94. doi: 10.1016/j.jdiacomp.2007.07.001. Epub 2008 Apr 16. J Diabetes Complications. 2008. PMID: 18413184 - Epithelial and connective tissue cell CTGF/CCN2 expression in gingival fibrosis.
Kantarci A, Black SA, Xydas CE, Murawel P, Uchida Y, Yucekal-Tuncer B, Atilla G, Emingil G, Uzel MI, Lee A, Firatli E, Sheff M, Hasturk H, Van Dyke TE, Trackman PC. Kantarci A, et al. J Pathol. 2006 Sep;210(1):59-66. doi: 10.1002/path.2000. J Pathol. 2006. PMID: 16841303 Free PMC article. - Connective tissue growth factor mediates the profibrotic effects of transforming growth factor-beta produced by tubular epithelial cells in response to high glucose.
Kobayashi T, Inoue T, Okada H, Kikuta T, Kanno Y, Nishida T, Takigawa M, Sugaya T, Suzuki H. Kobayashi T, et al. Clin Exp Nephrol. 2005 Jun;9(2):114-21. doi: 10.1007/s10157-005-0347-x. Clin Exp Nephrol. 2005. PMID: 15980944 - The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology.
Leask A, Abraham DJ. Leask A, et al. Biochem Cell Biol. 2003 Dec;81(6):355-63. doi: 10.1139/o03-069. Biochem Cell Biol. 2003. PMID: 14663501 Review. - Hypothesis: pathogenesis of systemic sclerosis.
Takehara K. Takehara K. J Rheumatol. 2003 Apr;30(4):755-9. J Rheumatol. 2003. PMID: 12672195 Review.
Cited by
- Mannose-binding lectin deficiency attenuates renal changes in a streptozotocin-induced model of type 1 diabetes in mice.
Østergaard J, Thiel S, Gadjeva M, Hansen TK, Rasch R, Flyvbjerg A. Østergaard J, et al. Diabetologia. 2007 Jul;50(7):1541-9. doi: 10.1007/s00125-007-0686-0. Epub 2007 May 1. Diabetologia. 2007. PMID: 17473913 - Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling.
Chung AC, Zhang H, Kong YZ, Tan JJ, Huang XR, Kopp JB, Lan HY. Chung AC, et al. J Am Soc Nephrol. 2010 Feb;21(2):249-60. doi: 10.1681/ASN.2009010018. Epub 2009 Dec 3. J Am Soc Nephrol. 2010. PMID: 19959709 Free PMC article. - Mastering a mediator: blockade of CCN-2 shows early promise in human diabetic kidney disease.
Twigg SM. Twigg SM. J Cell Commun Signal. 2010 Dec;4(4):189-96. doi: 10.1007/s12079-010-0102-2. Epub 2010 Oct 19. J Cell Commun Signal. 2010. PMID: 21234125 Free PMC article. - Myofibroblast progenitor cells are increased in number in patients with type 1 diabetes and express less bone morphogenetic protein 6: a novel clue to adverse tissue remodelling?
Nguyen TQ, Chon H, van Nieuwenhoven FA, Braam B, Verhaar MC, Goldschmeding R. Nguyen TQ, et al. Diabetologia. 2006 May;49(5):1039-48. doi: 10.1007/s00125-006-0172-0. Epub 2006 Mar 18. Diabetologia. 2006. PMID: 16547600 - Quantitative assessment of macular contraction and vitreoretinal interface alterations in diabetic macular edema treated with intravitreal anti-VEGF injections.
Cetin EN, Demirtaş Ö, Özbakış NC, Pekel G. Cetin EN, et al. Graefes Arch Clin Exp Ophthalmol. 2018 Oct;256(10):1801-1806. doi: 10.1007/s00417-018-4042-5. Epub 2018 Jun 20. Graefes Arch Clin Exp Ophthalmol. 2018. PMID: 29922890
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous